Press

Deep functional measurements of Fragile X Syndrome human neurons reveal multiparametric electrophysiological disease phenotype

A phenotypic screening platform for chronic pain therapeutics using all-optical electrophysiology

Discovery of novel compounds and target mechanisms using a high throughput, multiparametric phenotypic screen in a human neuronal model of Tuberous Sclerosis

Highly Parallelized, Multicolor Optogenetic Recordings of Cellular Activity for Therapeutic Discovery Applications in Ion Channels and Disease-Associated Excitable Cells

Developing antisense oligonucleotides for a TECPR2 mutation-induced, ultra-rare neurological disorder using patient-derived cellular models

Probing Synaptic Signaling with Optogenetic Stimulation and Genetically Encoded Calcium Reporters

Align Summit: Cambridge based Quiver Bioscience is developing ASOs for CNS conditions, including programs in the red hot Nav1.7/1.8 pain space

Quiver Bioscience secures non-dilutive funding to enhance CNS genetic medicine drug discovery platform capabilities and advance powerful AI/ML-based in vitro / in silico predictor of CNS drug safety

Quiver Bioscience Appoints Graham Dempsey, PhD as Chief Executive Officer to Lead Scaling of AI-Driven CNS Platform and Advance Lead Program into the Clinic

Quiver Bioscience and QurAlis Announce Research Collaboration to Advance Novel Therapeutic Approach for Fragile X Syndrome

Quiver Bioscience Announces Collaboration with the Dup15q Alliance to Advance Antisense Oligonucleotide Therapeutic Program

Quiver Bioscience Announces Publication in Nature Communications Biology Detailing Application of the Quiver Genomic Positioning System (Brain GPS) to Therapeutic Discovery in Fragile X Syndrome using Human Models and Machine Learning Analysis

Genomic Positioning System (GPS): High-resolution, high throughput electrophysiology integrated with AI/ML to map diseases, targets, and drugs for CNS therapeutic discovery

High-throughput profiling of the effects of genetic perturbations on electrophysiology in human neurons

Discovery of optimized therapeutics for CNS disorders using the brain Genomic Positioning System (GPS)

Development of Nav1.7 channel targeting antisense oligonucleotide as a chronic pain therapeutic using an integrated platform based on machine learning and optical electrophysiology